The AKT1/NF-kappaB/Notch1/PTEN axis has an important role in chemoresistance of gastric cancer cells

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Zhou, W ^a,b   Fu, X Q ^a   Zhang, L L ^a   Zhang, J ^a   Huang, X ^a   Lu, X H ^a   Shen, L ^a   Liu, B N ^a   Liu, J ^a   Luo, H S ^a   Yu, J P ^a   Yu, H G ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b First Hospital of Wuhan   (China)

Author keywords

AKT1; Gastric cancer; NF kappaB; Notch 1; PTEN

Indexed keywords

DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH MUCOSA; UPREGULATION; XENOGRAFT;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84887437470     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.375     Document Type: Article

References (39)

1. Basu B, Yap TA, Molife LR, de Bono JS. Targeting the DNA damage response in oncology: Past, present and future perspectives. Curr Opin Oncol 2012; 24: 316-324
2. Koo DH, Lee JL, Kim TW, Chang HM, Ryu MH, Yook Jh et al. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma. Eur J Surg Oncol 2007; 33: 843-848
3. Kulke MH, Wu B, Clark JW, Enzinger PC, Lynch TJ, Vincitore M et al. A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagus. Cancer Invest 2006; 24: 229-234
4. Galluzzi L, Larochette N, Zamzami N, Kroemer G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 2006; 25: 4812-4830
5. Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25: 4798-4811
6. Wen Y, Gorsic LK, Wheeler H, Ziliak D, Huang RS, Dolan MB. Chemotherapeutic-induced apoptosis: A phenotype for pharmacogenomics studies. Pharmacogenet Genomics 2011; 21: 476-488
7. Hernandez-Aya LF, Gonzalez-Angulo AM. Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer. Oncologist 2011; 16: 404-414
8. Hay M. Interplay between FOXO, TOR, and Akt. Biochim Biophys Acta 2011; 1813: 1965-1970
9. Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH et al. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer 2008; 122: 433-443
10. Zhang S, Yu D. PI(3)king apart PTENs role in cancer. Clin Cancer Res 2010; 16: 4325-4530
11. Davies MA, Koul D, Dhesi H, Berman R, McDonnell TJ, McConkey D et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 1999; 59: 2551-2556
12. Yu J, Zhang SS, Saito K, Williams S, Arimura Y, Ma Y et al. PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J 2009; 28: 21-33
13. Kim J, Lee YH, Kwon TK, Chang JS, Chung KC, Min DS. Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10. Cancer Res 2006; 66: 784-793
14. Whelan JT, Kellogg A, Shewchuk BM, Hewan-Lowe K, Bertrand FE. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression. J Cell Biochem 2009; 107: 992-1001
15. Whelan JT, Forbes SL, Bertrand FE. CBF-1 (RBP-J kappa) binds to the PTEN promoter and regulates PTEN gene expression. Cell Cycle 2007; 6: 80-84
16. Chappell WH, Green TD, Spengeman JD, McCubrey JA, Akula SM, Bertrand FE. Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active Notch-1. Cell Cycle 2005; 4: 1389-1395
17. Chillakuri CR, Sheppard D, Lea SM, Handford PA. Notch receptor-ligand binding and activation: Insights from molecular studies. Semin Cell Dev Biol 2012; 23: 421-428
18. Hansson EM, Lendahl U, Chapman G. Notch signaling in development and disease. Semin Cancer Biol 2004; 14: 320-328
19. Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ, Powell MB. Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 2008; 118: 3660-3670
20. Del Bianco C, Aster JC, Blacklow SC. Mutational and energetic studies of Notch-1 transcription complexes. J Mol Biol 2008; 376: 131-140
21. Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich D. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood 2004; 103: 3503-3510
22. Eliasz S, Liang S, Chen Y, De Marco MA, Machek O, Skucha S et al. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene 2010; 29: 2488-2498
23. Hao L, Rizzo P, Osipo C, Pannuti A, Wyatt D, Cheung LW et al. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene 2010; 29: 201-213
24. Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB et al. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res 2009; 69: 573-582
25. Sjölund J, Johansson M, Manna S, Norin C, Pietras A, Beckman S et al. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest 2008; 118: 217-228
26. Kunnimalaiyaan M, Traeger K, Chen H. Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol 2005; 289: G636-G642
27. Li Z, Oh DY, Nakamura K, Thiele CJ. Perifosine-induced inhibition of Akt attenuates BDNF/ TrkB-induced chemoresistance in neuroblastoma in vivo. Cancer 2011; 117: 5412-5422
28. Chen W, Bai L, Wang X, Xu S, Belinsky SA, Lin Y. Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis. Mol Pharmacol 2010; 77: 416-423
29. Abedini MR, Muller EJ, Bergeron R, Gray DA, Tsang BK. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein. Oncogene 2010; 29: 11-25
30. Park S, Kim D, Kaneko S, Szewczyk KM, Nicosia SV, Yu H et al. Molecular cloning and characterization of the human AKT1 promoter uncovers its up-regulation by the Src/Stat3 pathway. J Biol Chem 2005; 280: 38932-38941
31. Madamanchi NR, Li S, Patterson C, Runge MS. Reactive oxygen species regulate heatshock protein 70 via the JAK/STAT pathway. Arterioscler Thromb Vasc Biol 2001; 21: 321-326
32. Li F, Sethi G. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta 2010; 1805: 167-180
33. Bash J, Zong WX, Banga S, Rivera A, Ballard DW, Ron Y et al. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO J 1999; 18: 2803-2811
34. Kunnimalaiyaan M, Chen H. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Oncologist 2007; 12: 535-542
35. Palomero T, Dominguez M, Ferrando AA. The role of the PTEN/AKT pathway in NOTCH1-induced leukemia. Cell Cycle 2008; 7: 965-970
36. Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell 2008; 133: 403-414
37. Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner C et al. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev 1998; 12: 2269-2277
38. Hsieh JJ, Zhou S, Chen L, Young DB, Hayward SD. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci USA 1999; 96: 23-28
39. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y et al. Regulation of PTEN transcription by p53. Mol Cell 2001; 8: 317-325